Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
Open Access
- 31 May 2012
- journal article
- Published by Elsevier BV in Journal of Inorganic Biochemistry
- Vol. 110, 58-63
- https://doi.org/10.1016/j.jinorgbio.2012.02.012
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- Deutscher Akademischer Austauschdienst
- Deutscher Akademischer Austauschdienst
This publication has 35 references indexed in Scilit:
- Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin CytotoxicityChemBioChem, 2011
- Chlorotoxin Labeled Magnetic Nanovectors for Targeted Gene Delivery to GliomaACS Nano, 2010
- PEG-Mediated Synthesis of Highly Dispersive Multifunctional Superparamagnetic Nanoparticles: Their Physicochemical Properties and Function In VivoACS Nano, 2010
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic EffectsPublished by Elsevier BV ,2010
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetateProceedings of the National Academy of Sciences of the United States of America, 2009
- Peptide Targeting of Platinum Anti-Cancer DrugsBioconjugate Chemistry, 2009
- A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cellsBiomaterials, 2008
- In Vivo MRI Detection of Gliomas by Chlorotoxin‐Conjugated Superparamagnetic NanoprobesSmall, 2008
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor VasculatureBioconjugate Chemistry, 2007
- Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cellsCanadian Journal of Physiology and Pharmacology, 1999